LONDON, ONTARIO -- (MARKET WIRE) -- May 11, 2007 -- Stellar Pharmaceuticals Inc. (TSX VENTURE: SLX)(OTCBB: SLXCF) (“Stellar” or “the Company”), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced financial results for the first quarter ended March 31, 2007. All amounts in this press release are in Canadian dollars and are the result of the use of U.S. generally accepted accounting principles.
